Marathon Trading Investment Management Cut Time Warner (TWX) Position By $10.16 Million; Consonance Capital Management LP Lowered Its Gw Pharmaceuticals Plc (GWPH) Stake

June 14, 2018 - By Louis Casey

Time Warner Inc. (NYSE:TWX) Logo

Marathon Trading Investment Management Llc decreased Time Warner Inc (TWX) stake by 93.35% reported in 2018Q1 SEC filing. Marathon Trading Investment Management Llc sold 108,100 shares as Time Warner Inc (TWX)’s stock declined 1.16%. The Marathon Trading Investment Management Llc holds 7,700 shares with $728,000 value, down from 115,800 last quarter. Time Warner Inc now has $77.58B valuation. The stock increased 1.24% or $1.21 during the last trading session, reaching $99.16. About 18.40 million shares traded or 177.10% up from the average. Time Warner Inc. (NYSE:TWX) has declined 5.23% since June 14, 2017 and is downtrending. It has underperformed by 17.80% the S&P500. Some Historical TWX News: ; 26/04/2018 – Time Warner Anticipates Flat to Low-Single-Digit Growth for Turner’s Total Advertising Rev in 2Q; 15/03/2018 – JUDGE RICHARD LEON ALSO SAID AT&T TRIAL COULD LAST SIX TO EIGHT WEEKS; 15/05/2018 – VIACOM INC VIAB.O – AT&T AND TIME WARNER, l CERTAINLY DIDN’T EXPECT THAT DEAL TO BE SUBJECT TO THE SITUATION IT’S IN NOW-CEO, CONF CALL; 30/04/2018 – U.S. argues AT&T hiding real consumer impact of Time Warner deal; 30/05/2018 – STEPHENSON SAYS AT&T HOPED TO GAIN INSIGHT FROM COHEN INTO TRUMP BUT HIRING WAS A ‘BAD MISTAKE’; 09/05/2018 – Stormy Daniels’ lawyer questions dealings as companies defend Trump attorney payments; 26/04/2018 – TIME WARNER REAFFIRMS 2018 YEAR OUTLOOK; 02/04/2018 – Time Warner Closes Above 50-Day Moving Average: Technicals; 30/04/2018 – The Justice Department said AT&T sought to hide the high cost to consumers of its $85-billion deal to buy Time Warner; 09/04/2018 – Time Warner/AT&T: Shapiro expected to testify Wednesday – source [17:29 BST09 Apr 2018] [Proprietary] []

Consonance Capital Management Lp decreased Gw Pharmaceuticals Plc (GWPH) stake by 59.63% reported in 2018Q1 SEC filing. Consonance Capital Management Lp sold 402,792 shares as Gw Pharmaceuticals Plc (GWPH)’s stock rose 36.14%. The Consonance Capital Management Lp holds 272,700 shares with $30.73 million value, down from 675,492 last quarter. Gw Pharmaceuticals Plc now has $4.20B valuation. The stock decreased 1.89% or $2.8668 during the last trading session, reaching $148.9432. About 320,670 shares traded. GW Pharmaceuticals plc (NASDAQ:GWPH) has risen 49.14% since June 14, 2017 and is uptrending. It has outperformed by 36.57% the S&P500. Some Historical GWPH News: ; 17/04/2018 – GW PHARMA’S CANNABIDIOL DRUG GETS FAVORABLE FDA STAFF REVIEW; 17/04/2018 – Top 3 today — #1 GW Pharma’s cannabis-based drug appears poised for a groundbreaking FDA approval as internal review offers a clear thumbs up $GWPH; 16/05/2018 – GW Pharmaceuticals: Epidiolex Reduced Monthly Frequency of Drop Seizures; 24/05/2018 – Isodiol Intl Inc. Signs Letter of Intent to Supply 99.5%+ Cannabidiol Isolate to Sundial; 13/03/2018 – GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents; 17/04/2018 – FDA POSTS BRIEFING ON GW PHARMA DRUG AHEAD OF ADVISERS MEETING; 04/05/2018 – lsodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis; 19/04/2018 – GW PHARMACEUTICALS TO RESUME TRADING AT 1:15 P.M; 30/04/2018 – Projects will not be focusing on the cannabis plant’s psychoactive compound, known as tetrahydrocannabinol, or THC; 08/05/2018 – GW PHARMACEUTICALS PLC – QTRLY LOSS PER ADS 312.0 CENTS

Marathon Trading Investment Management Llc increased Ishares Silver Trust (SLV) stake by 22,300 shares to 48,000 valued at $740,000 in 2018Q1. It also upped Spdr Gold Trust (GLD) stake by 100,303 shares and now owns 105,003 shares. Spdr Series Trust (XOP) was raised too.

Among 41 analysts covering Time Warner Inc. (NYSE:TWX), 16 have Buy rating, 0 Sell and 25 Hold. Therefore 39% are positive. Time Warner Inc. had 128 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Hold” on Monday, September 11. The stock has “Market Perform” rating by Wells Fargo on Thursday, November 5. The stock of Time Warner Inc. (NYSE:TWX) earned “Hold” rating by BMO Capital Markets on Monday, October 16. On Monday, October 24 the stock rating was downgraded by Pivotal Research to “Hold”. As per Thursday, April 20, the company rating was downgraded by Pivotal Research. Pivotal Research downgraded Time Warner Inc. (NYSE:TWX) on Tuesday, April 17 to “Hold” rating. Morgan Stanley maintained the stock with “Equal-Weight” rating in Tuesday, April 26 report. Topeka Capital Markets maintained Time Warner Inc. (NYSE:TWX) on Thursday, October 8 with “Buy” rating. The rating was maintained by Jefferies on Tuesday, May 23 with “Buy”. Bank of America downgraded Time Warner Inc. (NYSE:TWX) on Thursday, November 5 to “Neutral” rating.

Investors sentiment increased to 0.98 in Q1 2018. Its up 0.07, from 0.91 in 2017Q4. It is positive, as 68 investors sold TWX shares while 336 reduced holdings. 98 funds opened positions while 299 raised stakes. 589.17 million shares or 1.52% less from 598.25 million shares in 2017Q4 were reported. New Jersey Better Educational Savings Trust reported 17,000 shares. Ls Inv Advsrs Limited Liability owns 19,377 shares. Conning has invested 0.06% in Time Warner Inc. (NYSE:TWX). Dowling And Yahnke Ltd holds 0.55% in Time Warner Inc. (NYSE:TWX) or 61,684 shares. Whittier Tru accumulated 41,840 shares. Ing Groep Nv reported 381,680 shares or 0.65% of all its holdings. Telos Management Inc holds 1.12% in Time Warner Inc. (NYSE:TWX) or 33,446 shares. Reaves W H & Com reported 2.14% of its portfolio in Time Warner Inc. (NYSE:TWX). Ascend Cap Limited Liability Corp accumulated 506,956 shares. Cubist Systematic Strategies Llc owns 8,488 shares. Reliance Company Of Delaware stated it has 17,449 shares. Consolidated Gp Lc holds 2.11% of its portfolio in Time Warner Inc. (NYSE:TWX) for 46,195 shares. Aviva Plc owns 395,232 shares for 0.23% of their portfolio. Edge Wealth Mgmt Llc owns 0% invested in Time Warner Inc. (NYSE:TWX) for 100 shares. First Manhattan invested in 582,452 shares or 0.31% of the stock.

Analysts await Time Warner Inc. (NYSE:TWX) to report earnings on August, 1. They expect $1.58 earnings per share, up 18.80% or $0.25 from last year’s $1.33 per share. TWX’s profit will be $1.24B for 15.69 P/E if the $1.58 EPS becomes a reality. After $2.28 actual earnings per share reported by Time Warner Inc. for the previous quarter, Wall Street now forecasts -30.70% negative EPS growth.

More notable recent Time Warner Inc. (NYSE:TWX) news were published by: Seekingalpha.com which released: “AT&T Hits Rock Bottom – Buy Or Beware?” on June 14, 2018, also Finance.Yahoo.com with their article: “With or Without Time Warner, AT&T Stock Isn’t Worth Buying” published on June 13, 2018, Seekingalpha.com published: “Vanity Fair: Zucker staying at CNN through ’20 election” on June 13, 2018. More interesting news about Time Warner Inc. (NYSE:TWX) were released by: Streetinsider.com and their article: “After-Hours Stock Movers 06/12: (ENPH) (FOXA) (TWX) Higher; (VTVT) (HRB) (OXM) Lower (more…)” published on June 12, 2018 as well as Seekingalpha.com‘s news article titled: “Headlines Don’t Determine Stock Prices – Cramer’s Mad Money (6/12/18)” with publication date: June 13, 2018.

Since February 5, 2018, it had 0 buys, and 2 selling transactions for $766,866 activity. BARR WILLIAM P also sold $390,647 worth of Time Warner Inc. (NYSE:TWX) on Monday, February 5. WRIGHT DEBORAH C had sold 4,019 shares worth $376,219.

Among 13 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 11 have Buy rating, 1 Sell and 1 Hold. Therefore 85% are positive. GW Pharmaceuticals had 30 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Monday, September 25. Maxim Group maintained GW Pharmaceuticals plc (NASDAQ:GWPH) on Thursday, June 8 with “Buy” rating. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Bank of America on Tuesday, November 14. Bank of America maintained the shares of GWPH in report on Tuesday, February 6 with “Buy” rating. Morgan Stanley initiated the stock with “Overweight” rating in Thursday, August 13 report. Cantor Fitzgerald initiated GW Pharmaceuticals plc (NASDAQ:GWPH) on Friday, June 3 with “Buy” rating. The firm has “Buy” rating by Maxim Group given on Monday, August 7. The firm has “Buy” rating given on Tuesday, April 17 by Cantor Fitzgerald. The firm earned “Buy” rating on Monday, December 5 by Cantor Fitzgerald. Goldman Sachs upgraded GW Pharmaceuticals plc (NASDAQ:GWPH) on Thursday, December 14 to “Buy” rating.

Analysts await GW Pharmaceuticals plc (NASDAQ:GWPH) to report earnings on August, 6. They expect $-2.39 earnings per share, down 15.46% or $0.32 from last year’s $-2.07 per share. After $-3.12 actual earnings per share reported by GW Pharmaceuticals plc for the previous quarter, Wall Street now forecasts -23.40% EPS growth.

Consonance Capital Management Lp increased Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stake by 521,112 shares to 4.99 million valued at $11.94M in 2018Q1. It also upped Retrophin Inc (NASDAQ:RTRX) stake by 48,933 shares and now owns 3.69M shares. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was raised too.

More notable recent GW Pharmaceuticals plc (NASDAQ:GWPH) news were published by: Nasdaq.com which released: “Why Marijuana Stock GW Pharmaceuticals Gained 21% in May” on June 14, 2018, also Fool.com with their article: “Better Marijuana Stock: GW Pharmaceuticals vs. Cara Therapeutics” published on June 10, 2018, Seekingalpha.com published: “GW Pharmaceuticals: Value Beyond Epidiolex?” on June 04, 2018. More interesting news about GW Pharmaceuticals plc (NASDAQ:GWPH) were released by: Fool.com and their article: “Better Marijuana Stock: Scotts Miracle-Gro vs. GW Pharmaceuticals” published on June 03, 2018 as well as Fool.com‘s news article titled: “3 Biotechs With Huge FDA Decisions in June” with publication date: May 31, 2018.

Time Warner Inc. (NYSE:TWX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: